Uae Deep Brain Stimulation Parkinsons Disease Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030
Description
UAE Deep Brain Stimulation Parkinson's Disease
Market Overview
The UAE Deep Brain Stimulation market is valued at USD 130 million, based on a five-year historical analysis, in line with the size of the broader UAE Parkinson’s disease treatment market and the share of Parkinson’s disease in global deep brain stimulation applications. This growth is primarily driven by the increasing prevalence of Parkinson's disease, aging demographics, advancements in neuromodulation technologies (such as directional leads and rechargeable pulse generators), and rising awareness about surgical treatment options among patients and healthcare providers. Key cities such as Dubai and Abu Dhabi dominate the market due to their advanced healthcare infrastructure, availability of specialized movement-disorder and functional neurosurgery centers, and a high concentration of healthcare professionals trained in neurosurgery and movement disorders. These cities also attract international patients seeking advanced treatment options, supported by strong medical tourism initiatives and accreditation of tertiary hospitals. In 2023, the UAE government strengthened its medical device oversight through the Medical Devices Interim Regulation issued under Federal Law No. 4 of 2015 on Private Health Facilities and subsequent technical regulations and circulars by the Ministry of Health and Prevention (MoHAP), which mandate that all medical devices, including deep brain stimulators, must be registered in the MoHAP Medical Devices Registration system, demonstrate conformity with UAE.S GSO / Gulf and international standards, undergo appropriate clinical evaluation, and obtain marketing authorization before being imported, distributed, or used in healthcare facilities. This framework aims to ensure patient safety, post?market surveillance, and the efficacy of medical devices used in the treatment of neurological disorders.
UAE Deep Brain Stimulation Parkinson's Disease
Market Segmentation
By Product Type: The product type segmentation includes various categories of deep brain stimulators and their accessories. The market is characterized by a diverse range of products, with dual-channel deep brain stimulators leading the way due to their advanced capabilities, ability to stimulate bilateral targets, and strong clinical evidence for improving Parkinson's disease motor symptoms. Single-channel stimulators and accessories also play significant roles, catering to specific patient needs, device replacement cycles, and hospital procurement preferences. By Target Indication (DBS in Parkinson’s Disease): The target indication segmentation focuses on the specific types of Parkinson's disease that deep brain stimulation addresses. Tremor-dominant Parkinson's disease is a major indication for DBS, as the therapy is particularly effective for medication-refractory tremor and motor fluctuations, which supports strong demand for surgical intervention. Akinetic-rigid and mixed-type Parkinson's disease also contribute significantly to the market, as they require tailored programming strategies and long-term neurology follow-up to optimize symptom control.
UAE Deep Brain Stimulation Parkinson's Disease Market
Competitive Landscape
The UAE Deep Brain Stimulation Parkinson's Disease Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories (Abbott Neuromodulation), Aleva Neurotherapeutics SA, Beijing PINS Medical Co., Ltd., SceneRay Co., Ltd., LivaNova PLC, Functional Neuromodulation Ltd., Nevro Corp, NeuroPace, Inc., National Neuroscience Institute – King Faisal Specialist Hospital & Research Centre (regional reference center), Cleveland Clinic Abu Dhabi – Neurological Institute, Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, Rashid Hospital & Dubai Health (Dubai Academic Health Corporation), Mediclinic City Hospital, Dubai contribute to innovation, geographic expansion, and service delivery in this space.
Medtronic plc
1949 Dublin, Ireland
Boston Scientific Corporation
1979 Marlborough, USA
Abbott Laboratories
1888 Abbott Park, USA
LivaNova PLC
2015 London, UK
Functional Neuromodulation Ltd. 2011 Toronto, Canada
Company
Establishment Year
Headquarters
Global DBS Revenue (USD million)
Estimated UAE DBS Parkinson’s Procedure Share (%)
Installed Base of DBS Systems in UAE (units)
CAGR of DBS Sales in GCC / Middle East (%)
Average Selling Price per DBS System in UAE (USD)
Share of Rechargeable vs Non?rechargeable Systems (%)
UAE Deep Brain Stimulation Parkinson's Disease Market Industry Analysis
Growth Drivers
Increasing Prevalence of Parkinson's Disease: The UAE has witnessed a significant rise in Parkinson's disease cases, with estimates indicating that approximately 25,000 individuals are currently diagnosed. This increase is attributed to an aging population, as the World Bank projects that the percentage of the population aged 65 and older will reach 15% in future. Consequently, the demand for effective treatment options, including Deep Brain Stimulation (DBS), is expected to surge, driving market growth. Advancements in Deep Brain Stimulation Technology: Technological innovations in DBS have led to improved outcomes for patients with Parkinson's disease. For instance, the introduction of directional leads and closed-loop systems has enhanced the precision of stimulation. According to industry reports, the global market for DBS devices is projected to reach USD 2 billion in future, indicating a robust interest in advanced treatment modalities. This trend is expected to positively impact the UAE market as healthcare providers adopt these technologies. Growing Awareness and Acceptance of DBS Treatments: Awareness campaigns and educational initiatives have significantly increased the acceptance of DBS among patients and healthcare professionals in the UAE. Reports indicate that over 70% of neurologists now recommend DBS as a viable treatment option for Parkinson's disease. This shift in perception is crucial, as it encourages more patients to consider surgical interventions, thereby expanding the market for DBS therapies in the region.
Market Challenges
High Cost of Deep Brain Stimulation Procedures: The financial burden associated with DBS procedures remains a significant challenge in the UAE. The average cost of a DBS surgery can exceed AED 120,000, which is prohibitive for many patients. Additionally, limited insurance coverage for such advanced treatments further exacerbates the issue, leading to a gap in access for those who could benefit from DBS, thus hindering market growth. Limited Access to Specialized Healthcare Facilities: Access to specialized healthcare facilities offering DBS is limited in the UAE, particularly in rural areas. Currently, only a handful of hospitals are equipped to perform these complex procedures, which restricts patient access. According to the UAE Ministry of Health, only 7% of hospitals in the country provide advanced neurological services, creating a significant barrier for patients seeking DBS treatment and limiting market expansion.
UAE Deep Brain Stimulation Parkinson's Disease Market
Future Outlook
The future of the UAE Deep Brain Stimulation market appears promising, driven by ongoing advancements in technology and increasing healthcare investments. As the government prioritizes neurological health, initiatives to enhance healthcare infrastructure are expected to facilitate better access to DBS treatments. Furthermore, the integration of telemedicine and AI in treatment planning will likely improve patient outcomes and streamline processes, making DBS more accessible and effective for those suffering from Parkinson's disease.
Market Opportunities
Expansion of Healthcare Infrastructure: The UAE government is investing heavily in healthcare infrastructure, with plans to increase the number of specialized neurological centers. This expansion is projected to enhance access to DBS treatments, potentially increasing patient enrollment by 40% in future, thereby creating a significant market opportunity for providers. Increasing Investment in Neurological Research: With a growing focus on neurological disorders, funding for research in DBS technologies is on the rise. The UAE allocated AED 600 million for neurological research in future, fostering innovation and development of new treatment modalities. This investment is expected to lead to breakthroughs that could enhance the efficacy of DBS, further driving market growth.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Market Overview
The UAE Deep Brain Stimulation market is valued at USD 130 million, based on a five-year historical analysis, in line with the size of the broader UAE Parkinson’s disease treatment market and the share of Parkinson’s disease in global deep brain stimulation applications. This growth is primarily driven by the increasing prevalence of Parkinson's disease, aging demographics, advancements in neuromodulation technologies (such as directional leads and rechargeable pulse generators), and rising awareness about surgical treatment options among patients and healthcare providers. Key cities such as Dubai and Abu Dhabi dominate the market due to their advanced healthcare infrastructure, availability of specialized movement-disorder and functional neurosurgery centers, and a high concentration of healthcare professionals trained in neurosurgery and movement disorders. These cities also attract international patients seeking advanced treatment options, supported by strong medical tourism initiatives and accreditation of tertiary hospitals. In 2023, the UAE government strengthened its medical device oversight through the Medical Devices Interim Regulation issued under Federal Law No. 4 of 2015 on Private Health Facilities and subsequent technical regulations and circulars by the Ministry of Health and Prevention (MoHAP), which mandate that all medical devices, including deep brain stimulators, must be registered in the MoHAP Medical Devices Registration system, demonstrate conformity with UAE.S GSO / Gulf and international standards, undergo appropriate clinical evaluation, and obtain marketing authorization before being imported, distributed, or used in healthcare facilities. This framework aims to ensure patient safety, post?market surveillance, and the efficacy of medical devices used in the treatment of neurological disorders.
UAE Deep Brain Stimulation Parkinson's Disease
Market Segmentation
By Product Type: The product type segmentation includes various categories of deep brain stimulators and their accessories. The market is characterized by a diverse range of products, with dual-channel deep brain stimulators leading the way due to their advanced capabilities, ability to stimulate bilateral targets, and strong clinical evidence for improving Parkinson's disease motor symptoms. Single-channel stimulators and accessories also play significant roles, catering to specific patient needs, device replacement cycles, and hospital procurement preferences. By Target Indication (DBS in Parkinson’s Disease): The target indication segmentation focuses on the specific types of Parkinson's disease that deep brain stimulation addresses. Tremor-dominant Parkinson's disease is a major indication for DBS, as the therapy is particularly effective for medication-refractory tremor and motor fluctuations, which supports strong demand for surgical intervention. Akinetic-rigid and mixed-type Parkinson's disease also contribute significantly to the market, as they require tailored programming strategies and long-term neurology follow-up to optimize symptom control.
UAE Deep Brain Stimulation Parkinson's Disease Market
Competitive Landscape
The UAE Deep Brain Stimulation Parkinson's Disease Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories (Abbott Neuromodulation), Aleva Neurotherapeutics SA, Beijing PINS Medical Co., Ltd., SceneRay Co., Ltd., LivaNova PLC, Functional Neuromodulation Ltd., Nevro Corp, NeuroPace, Inc., National Neuroscience Institute – King Faisal Specialist Hospital & Research Centre (regional reference center), Cleveland Clinic Abu Dhabi – Neurological Institute, Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, Rashid Hospital & Dubai Health (Dubai Academic Health Corporation), Mediclinic City Hospital, Dubai contribute to innovation, geographic expansion, and service delivery in this space.
Medtronic plc
1949 Dublin, Ireland
Boston Scientific Corporation
1979 Marlborough, USA
Abbott Laboratories
1888 Abbott Park, USA
LivaNova PLC
2015 London, UK
Functional Neuromodulation Ltd. 2011 Toronto, Canada
Company
Establishment Year
Headquarters
Global DBS Revenue (USD million)
Estimated UAE DBS Parkinson’s Procedure Share (%)
Installed Base of DBS Systems in UAE (units)
CAGR of DBS Sales in GCC / Middle East (%)
Average Selling Price per DBS System in UAE (USD)
Share of Rechargeable vs Non?rechargeable Systems (%)
UAE Deep Brain Stimulation Parkinson's Disease Market Industry Analysis
Growth Drivers
Increasing Prevalence of Parkinson's Disease: The UAE has witnessed a significant rise in Parkinson's disease cases, with estimates indicating that approximately 25,000 individuals are currently diagnosed. This increase is attributed to an aging population, as the World Bank projects that the percentage of the population aged 65 and older will reach 15% in future. Consequently, the demand for effective treatment options, including Deep Brain Stimulation (DBS), is expected to surge, driving market growth. Advancements in Deep Brain Stimulation Technology: Technological innovations in DBS have led to improved outcomes for patients with Parkinson's disease. For instance, the introduction of directional leads and closed-loop systems has enhanced the precision of stimulation. According to industry reports, the global market for DBS devices is projected to reach USD 2 billion in future, indicating a robust interest in advanced treatment modalities. This trend is expected to positively impact the UAE market as healthcare providers adopt these technologies. Growing Awareness and Acceptance of DBS Treatments: Awareness campaigns and educational initiatives have significantly increased the acceptance of DBS among patients and healthcare professionals in the UAE. Reports indicate that over 70% of neurologists now recommend DBS as a viable treatment option for Parkinson's disease. This shift in perception is crucial, as it encourages more patients to consider surgical interventions, thereby expanding the market for DBS therapies in the region.
Market Challenges
High Cost of Deep Brain Stimulation Procedures: The financial burden associated with DBS procedures remains a significant challenge in the UAE. The average cost of a DBS surgery can exceed AED 120,000, which is prohibitive for many patients. Additionally, limited insurance coverage for such advanced treatments further exacerbates the issue, leading to a gap in access for those who could benefit from DBS, thus hindering market growth. Limited Access to Specialized Healthcare Facilities: Access to specialized healthcare facilities offering DBS is limited in the UAE, particularly in rural areas. Currently, only a handful of hospitals are equipped to perform these complex procedures, which restricts patient access. According to the UAE Ministry of Health, only 7% of hospitals in the country provide advanced neurological services, creating a significant barrier for patients seeking DBS treatment and limiting market expansion.
UAE Deep Brain Stimulation Parkinson's Disease Market
Future Outlook
The future of the UAE Deep Brain Stimulation market appears promising, driven by ongoing advancements in technology and increasing healthcare investments. As the government prioritizes neurological health, initiatives to enhance healthcare infrastructure are expected to facilitate better access to DBS treatments. Furthermore, the integration of telemedicine and AI in treatment planning will likely improve patient outcomes and streamline processes, making DBS more accessible and effective for those suffering from Parkinson's disease.
Market Opportunities
Expansion of Healthcare Infrastructure: The UAE government is investing heavily in healthcare infrastructure, with plans to increase the number of specialized neurological centers. This expansion is projected to enhance access to DBS treatments, potentially increasing patient enrollment by 40% in future, thereby creating a significant market opportunity for providers. Increasing Investment in Neurological Research: With a growing focus on neurological disorders, funding for research in DBS technologies is on the rise. The UAE allocated AED 600 million for neurological research in future, fostering innovation and development of new treatment modalities. This investment is expected to lead to breakthroughs that could enhance the efficacy of DBS, further driving market growth.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
80 Pages
- 1. Uae Deep Brain Stimulation Parkinsons Disease Size, Share, Growth Drivers, Trends, Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Uae Deep Brain Stimulation Parkinsons Disease Size, Share, Growth Drivers, Trends, Opportunities & – Market Size (in USD Bn), 2019–2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Uae Deep Brain Stimulation Parkinsons Disease Size, Share, Growth Drivers, Trends, Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1 Increasing prevalence of Parkinson's disease in the UAE
- 3.1.2 Advancements in deep brain stimulation technology
- 3.1.3 Growing awareness and acceptance of surgical interventions
- 3.1.4 Supportive healthcare policies and funding for neurological treatments
- 3.2. Restraints
- 3.2.1 High costs associated with deep brain stimulation procedures
- 3.2.2 Limited availability of specialized healthcare professionals
- 3.2.3 Patient concerns regarding surgical risks and complications
- 3.2.4 Regulatory hurdles in medical device approvals
- 3.3. Opportunities
- 3.3.1 Expansion of healthcare infrastructure in the UAE
- 3.3.2 Increasing investment in neurological research and development
- 3.3.3 Potential for telemedicine in patient monitoring and follow-up
- 3.3.4 Collaborations between healthcare providers and technology firms
- 3.4. Trends
- 3.4.1 Rise in minimally invasive surgical techniques
- 3.4.2 Integration of artificial intelligence in treatment planning
- 3.4.3 Growing patient-centric approaches in treatment options
- 3.4.4 Increased focus on post-operative care and rehabilitation
- 3.5. Government Regulation
- 3.5.1 Regulatory frameworks for medical device approvals in the UAE
- 3.5.2 Guidelines for deep brain stimulation procedures
- 3.5.3 Policies promoting research and innovation in neurology
- 3.5.4 Compliance requirements for healthcare facilities performing DBS
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Uae Deep Brain Stimulation Parkinsons Disease Size, Share, Growth Drivers, Trends, Opportunities & – Market Segmentation, 2024
- 4.1. By Treatment Type (in Value %)
- 4.1.1 Surgical Interventions
- 4.1.2 Non-Surgical Interventions
- 4.1.3 Combination Therapies
- 4.1.4 Others
- 4.2. By Device Type (in Value %)
- 4.2.1 Implantable Pulse Generators
- 4.2.2 Electrodes
- 4.2.3 Accessories
- 4.3. By End-User (in Value %)
- 4.3.1 Hospitals
- 4.3.2 Neurology Clinics
- 4.3.3 Research Institutions
- 4.4. By Patient Demographics (in Value %)
- 4.4.1 Age Group
- 4.4.2 Gender
- 4.4.3 Socioeconomic Status
- 4.5. By Region (in Value %)
- 4.5.1 Abu Dhabi
- 4.5.2 Dubai
- 4.5.3 Sharjah
- 4.5.4 Others
- 4.6. By Market Type (in Value %)
- 4.6.1 Public Healthcare
- 4.6.2 Private Healthcare
- 4.6.3 Others
- 5. Uae Deep Brain Stimulation Parkinsons Disease Size, Share, Growth Drivers, Trends, Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1 Medtronic
- 5.1.2 Boston Scientific
- 5.1.3 Abbott Laboratories
- 5.1.4 St. Jude Medical
- 5.1.5 Nevro Corp
- 5.2. Cross Comparison Parameters
- 5.2.1 Revenue
- 5.2.2 Market Share
- 5.2.3 Product Portfolio
- 5.2.4 Geographic Presence
- 5.2.5 R&D Investment
- 6. Uae Deep Brain Stimulation Parkinsons Disease Size, Share, Growth Drivers, Trends, Opportunities & – Market Regulatory Framework
- 6.1. Medical Device Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Uae Deep Brain Stimulation Parkinsons Disease Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Size (in USD Bn), 2025–2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Uae Deep Brain Stimulation Parkinsons Disease Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Segmentation, 2030
- 8.1. By Treatment Type (in Value %)
- 8.2. By Device Type (in Value %)
- 8.3. By End-User (in Value %)
- 8.4. By Patient Demographics (in Value %)
- 8.5. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
